143 related articles for article (PubMed ID: 8640668)
1. Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers?
Sulh MA; Greco MA; Jiang T; Goswami SB; Present D; Steiner G
Cancer; 1996 May; 77(10):2044-51. PubMed ID: 8640668
[TBL] [Abstract][Full Text] [Related]
2. [Giant cell tumor of bone. Morphological, immunohistochemical, morphometric and DNA flow cytometric findings].
Kröber SM; Greschniok A; Böhm P; Kaiserling E
Verh Dtsch Ges Pathol; 1998; 82():279-83. PubMed ID: 10095447
[TBL] [Abstract][Full Text] [Related]
3. Quantitative pathological study of aggressiveness of giant cell tumor of bone.
Sun DQ; Feng CH; Fang JQ; Biesterfeld S; Boecking A
Chin Med J (Engl); 1991 Apr; 104(4):281-7. PubMed ID: 2065544
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of nitric oxide synthase mRNAs and proteins in giant cell tumors of bone].
Li HG; Pan CB; Zeng H; Zeng YJ; Shen XM; Dong SK
Ai Zheng; 2003 Nov; 22(11):1180-3. PubMed ID: 14613648
[TBL] [Abstract][Full Text] [Related]
5. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between surgical staging, pathologic grading, operative type and postoperative recurrence in giant cell tumor of bone].
Dong Z; Long M; Li H; Fu Y; Chen H
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):174-6. PubMed ID: 11938783
[TBL] [Abstract][Full Text] [Related]
7. Relationship between binuclear and multinuclear cells in giant cell tumor of bone.
Kusuzaki K; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(4):2463-7. PubMed ID: 10953311
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
10. [Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands].
Bankamp DG; Bierhoff E
Laryngorhinootologie; 1999 Feb; 78(2):77-80. PubMed ID: 10226990
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of primary and recurrent giant cell tumors of bone.
Rao UN; Goodman M; Chung WW; Swalski P; Pal R; Finkelstein S
Cancer Genet Cytogenet; 2005 Apr; 158(2):126-36. PubMed ID: 15796959
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
13. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.
Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W
J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356
[TBL] [Abstract][Full Text] [Related]
14. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
15. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in giant cell tumors of bone.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
[TBL] [Abstract][Full Text] [Related]
17. The effect of cellular proliferative activity on recurrence and local tumour extent of localized giant cell tumour of tendon sheath.
Kitagawa Y; Ito H; Yokoyama M; Sawaizumi T; Maeda S
J Hand Surg Br; 2004 Dec; 29(6):604-7. PubMed ID: 15542224
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 proliferation-index (MIB-1) of neurofibromas in neurofibromatosis type 1 patients.
Friedrich RE; Hagel C; Brehme Z; Kluwe L; Mautner VF
Anticancer Res; 2003; 23(2A):953-5. PubMed ID: 12820329
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.
Dewsnup NC; Susarla SM; Abulikemu M; Faquin WC; Kaban LB; August M
J Oral Maxillofac Surg; 2008 May; 66(5):928-33. PubMed ID: 18423282
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone.
Brecher ME; Franklin WA; Simon MA
Am J Pathol; 1986 Nov; 125(2):252-7. PubMed ID: 3789086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
